Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FE.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FE.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.3.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.3.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.95ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.95ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.95ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.95NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
ET.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
ET.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ET.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ET.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.34ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.34NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EN.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DV.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used